Showing results (131-140 of 187) with videos related to
Sort By:
Pageof 19
The New England Journal of Medicine|February 11, 1993
Idiopathic CD4+ T-lymphocytopenia--immunodeficiency without evidence of HIV infectionD D Ho, Y Cao, T Zhu, et al.Journal of Virology|June 11, 1999
Identification of human herpesvirus 8-specific cytotoxic T-cell responsesM Osman, T Kubo, J Gill, et al.AIDS (London, England)|December 13, 2002
An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individualsM Nelson, S Portsmouth, J Stebbing, et al.Thorax|June 1, 1991
Recovery of the human immunodeficiency virus from fibreoptic bronchoscopesP J Hanson, D Gor, J R Clarke, et al.International Journal of STD & AIDS|August 30, 2012
A dedicated clinic for HIV-positive individuals over 50 years of age: a multidisciplinary experienceL Waters, B Patterson, A Scourfield, et al.Journal of Virology|July 1, 1994
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndromeR A Koup, J T Safrit, Y Cao, et al.Antiviral Research|December 2, 1998
Summary of the II International Symposium on CytomegalovirusM D de Jong, G J Galasso, B Gazzard, et al.Clinical and Experimental Immunology|October 30, 1999
Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapyN Imami, G A Hardy, M R Nelson, et al.Clinical Pharmacology and Therapeutics|September 28, 2007
Pharmacokinetics and safety of saquinavir/ritonavir and omeprazole in HIV-infected subjectsK Singh, L Dickinson, A Chaikan, et al.AIDS (London, England)|August 16, 2001
Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNAN Clumeck, F Goebel, W Rozenbaum, et al.Pageof 19